Radiation pneumonitis and fibrosis: Mechanisms underlying its pathogenesis and implications for future research

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 5, 2006, Pages 1281-1293

  Tsoutsou, Pelagia G ^a   Koukourakis, Michael I ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Cytokines; Fibrosis; Pathogenesis; Radiation pneumonitis

Indexed keywords

BIOMEDICAL ENGINEERING; CELLS; ENGINEERING RESEARCH; PATHOLOGY;

CYTOKINES; FIBROSIS; PATHOGENESIS; RADIATION PNEUMONITIS;

RADIOTHERAPY;

ALPHA TOCOPHEROL; AMIFOSTINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CAPTOPRIL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBROBLAST GROWTH FACTOR; FLUTICASONE; FUMAGILLOL CHLOROACETYLCARBAMATE; IMATINIB; INFLIXIMAB; INTERLEUKIN 18; LUNG SURFACTANT; MESSENGER RNA; PALIFERMIN; PENTOXIFYLLINE; PIRFENIDONE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEASOME INHIBITOR; RECOMBINANT INTERLEUKIN 10; RELAXIN; SB 525334; SCATTER FACTOR; SU 9518; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; VANDETANIB;

AUTOCRINE EFFECT; BREAST ADENOCARCINOMA; CAPILLARY ENDOTHELIUM; CELL PROTECTION; CELL ULTRASTRUCTURE; CLINICAL FEATURE; COLLAGEN SYNTHESIS; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; IONIZING RADIATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROSIS; LUNG PARENCHYMA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIATION DOSE; RADIATION INJURY; RADIATION MUTAGENESIS; RADIATION PNEUMONIA; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RNA TRANSLATION; SYSTEMIC SCLEROSIS; TH1 CELL; TH2 CELL; TIGHT JUNCTION;

CYTOKINES; HUMANS; INCIDENCE; RADIATION PNEUMONITIS;

EID: 33751185152     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.08.058     Document Type: Review

References (147)

1. In: Rubin P., and Casseratt G.W. (Eds). Clinical radiation pathology. 3rd ed. Vol. 1 (1968), WB Saunders, Philadelphia 423-470
2. Morgan G.W., and Breit S.N. Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 31 (1995) 361-369
3. Reckzeh B., Merte H., Pfluger K.-H., et al. Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small cell lung cancer. J Clin Oncol 14 (1996) 1071-1076
4. Yu T.K., Whitman G.J., Thames H.D., et al. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst 96 (2004) 1676-1681
5. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
6. Lind P.A., Marks L.B., Hollis D., et al. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54 (2002) 340-347
7. Kasten-Pisula U., Tastan H., and Dikomey E. Huge differences in cellular radiosensitivity due to only very small variations in double-strand break repair capacity. Int J Radiat Biol 81 (2005) 409-419
8. Kong F.M., Anscher M.S., Sporn T.A., et al. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Int J Radiat Oncol Biol Phys 49 (2001) 35-41
9. McDonald S., Rubin P., Phillips T.L., et al. Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 31 (1995) 1187-1203
10. Mah K., Van Dyk J., Keane T., et al. Acute radiation-induced pulmonary damage: A clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 13 (1987) 179-188
11. Seppenwoolde Y., De Jaeger K., Boersma L.J., et al. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 748-758
12. Libshitz H.I., and Shuman L.S. Radiation induced pulmonary change: CT findings. J Comput Assist Tomogr 8 (1984) 15-19
13. Pavy J.J., Denekamp J., Letschert J., et al., EORTC Late Effects Working Group. Late effects toxicity scoring: The SOMA scale. Radiother Oncol 35 (1995) 11-15
14. Miller K.L., Kocak Z., Kahn D., et al. Preliminary report of the 6-minute walk test as a predictor of radiation-induced pulmonary toxicity. Int J Radiat Oncol Biol Phys 62 (2005) 1009-1013
15. Gross T.J., and Hunninghake G.W. Idiopathic pulmonary fibrosis. N Engl J Med 345 (2001) 517-525
16. Rubin P., Johnston C.J., Williams J.P., et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33 (1995) 99-109
17. Colloy T.V., and Yousem S.A. Lungs. In: Stenberg S.S. (Ed). Histology for pathologists. 1st ed. (1992), Raven Press, New York 479-481
18. Rubin P., Siemann D.W., Shapiro D.L., et al. Surfactant release as an early measure of radiation pneumonitis. Int J Radiat Oncol Biol Phys 9 (1983) 1669-1673
19. Kapanci Y., Ribaux C., Chaponnier C., et al. Cytoskeletal features of alveolar myofibroblasts and pericytes in normal human and rat lung. J Histochem Cytochem 40 (1992) 1955-1963
20. Roberts C.R., Walker D.C., and Schellenberg R.R. Extracellular matrix. Clin Allergy Immunol 16 (2002) 143-178
21. Rosai J. Acute pulmonary injury and interstitial pneumonia. In: Rosia J. (Ed). Ackerman's surgical pathology. 8th ed. Vol. 1 (1996), Mosby, New York 358-359
22. Gross N.J. Experimental radiation pneumonitis: IV. Leakage of circulatory proteins onto the alveolar surface. J Lab Clin Med 95 (1980) 19-31
23. Abdollahi A., Li M., Ping G., et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 201 (2005) 925-935
24. Travis E.L., Hanley R.A., Fenn J.O., et al. Pathologic changes in the lung following single and multifraction radiation. Int J Radiat Oncol Biol Phys 2 (1977) 475-490
25. Boerma M., van der Wees C.G., Vrieling H., et al. Microarray analysis of gene expression profiles of cardiac myocytes and fibroblasts after mechanical stress, ionising or ultraviolet radiation. BMC Genomics 6 (2005) 6
26. Christiansen H., Batusic D., Saile B., et al. Identification of genes responsive to gamma radiation in rat hepatocytes and rat liver by cDNA array gene expression analysis. Radiat Res 165 (2006) 318-325
27. Lu X., de la Pena L., Barker C., et al. Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes. Cancer Res 66 (2006) 1052-1061
28. Ward P.A., and Hunninghake G.W. Lung inflammation and fibrosis. Am J Respir Crit Care Med 157 Suppl (1998) 123-129
29. Mosmann T.R.H., Cherwinski M.W., et al. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. Bond. J Immunol 136 (1986) 2348-2359
30. Piguet P.-F. Cytokines involved in pulmonary fibrosis. Int Rev Exp Pathol 34 (1993) 173-181
31. 1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 163 (2001) 152-157
32. Fine A., and Goldstein R.H. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 262 (1987) 3897-3902
33. Finkelstein J.N., Johnson C.J., Baggs R., et al. Early alterations in extracellular matrix and transforming growth factor β gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys 28 (1994) 621-631
34. Rube C.E., Uthe D., Schmid K.W., et al. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys 47 (2000) 1033-1042
35. 1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41 (1998) 1029-1035
36. Fu X., Huang H., Bentel G., et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 50 (2001) 899-908
37. Kong F.-M., Washington M.K., Jirtle R.L., et al. Plasma transforming growth factor β1 reflects disease status in patients with lung cancer after radiotherapy: A possible tumor marker. Lung Cancer 16 (1996) 47-59
38. Anscher M.S., Kong F.M., et al. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. In regard to De Jaeger. Int J Radiat Oncol Biol Phys 61 (2005) 1276-1277
39. Assoian R.K., Fleurdelys B.E., Stevenson H.C., et al. Expression and secretion of transforming growth factor-β by activated human macrophages. Proc Natl Acad Sci USA 84 (1987) 6020-6024
40. Sacco O., Romberger D., Rizzino A., et al. Spontaneous production of transforming growth factor-β2 by primary cultures of bronchial epithelial cells. J Clin Invest 90 (1992) 1379-1385
41. Barcellos-Hoff M.H. Redox mechanisms for activation of latent transforming growth factor-beta 1. Mol Endocrinol 10 (1996) 1077-1083
42. Edwards D.R., Murphy G., Reynolds J.J., et al. Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6 (1987) 1899-1904
43. Nishioka A., Ogawa Y., Mima T., et al. Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-beta) receptor mediated by adenoviral vector. Int J Radiat Oncol Biol Phys 58 (2004) 1235-1241
44. Haimovitz-Friedman A., Balaban N., McLoughlin M., et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 54 (1994) 2591-2597
45. Danilenko D.M. Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol Pathol 27 (1999) 64-71
46. Zhang F., Nielsen L.D., Lucas J.J., et al. Transforming growth factor-beta antagonizes alveolar type II cell proliferation induced by keratinocyte growth factor. Am J Respir Cell Mol Biol 31 (2004) 679-686
47. Tagashira S., Harada H., Katsumata T., et al. Cloning of mouse FGF10 and up-regulation of its gene expression during wound healing. Gene 197 (1997) 399-404
48. Lebeche D., Malpel S., and Cardoso W.V. Fibroblast growth factor interactions in the developing lung. Mech Dev 86 (1999) 125-136
49. Chelly N., Henrion A., Pinteur C., et al. Role of keratinocyte growth factor in the control of surfactant synthesis by fetal lung mesenchyme. Endocrinology 142 (2001) 1814-1819
50. Adamson I.Y.R., and Bakowska J. Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin. Am J Pathol 155 (1999) 949-954
51. Brauchle M., Angermeyer K., Hubner G., et al. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 9 (1994) 3199-3204
52. Brauchle M., Fassler R., and Werner S. Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing. J Invest Dermatol 105 (1995) 579-584
53. Finlay G.A., Thannickal V.J., Fanburg B.L., et al. Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J Biol Chem 275 (2000) 27650-27656
54. Girinsky T. Effects of ionizing radiation on the blood vessel wall. J Mal Vasc 25 (2000) 321-324
55. Haimovitz-Friedman A., Vlodavsky I., Chaudhuri A., et al. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 51 (1991) 2552-2558
56. Gridley D.S., Bonnet R.B., Bush D.A., et al. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 759-766
57. Sato Y., and Rifkin D.B. Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 107 (1988) 1199-1205
58. Piguet P.-F. Is "tumor necrosis factor" the major effector of pulmonary fibrosis?. Eur Cytokine Netw 1 (1990) 257-258
59. Hong J.H., Jung S.M., Tsao T.C., et al. Bronchoalveolar lavage and interstitial cells have different roles in radiation-induced lung injury. Int J Radiat Biol 79 (2003) 159-167
60. Piguet P.F., Collart M.A., Grau G.E., et al. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 170 (1989) 655-663
61. Vujaskovic Z., Anscher M.S., Feng Q.F., et al. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 50 (2001) 851-855
62. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64 (2002) 993-998
63. Semenza G.L. Involvement of hypoxia-inducible factor 1 in pulmonary pathophysiology. Chest 128 Suppl (2005) 592S-594S
64. 1 induction of VEGF production in lung fibroblasts. Biochem Biophys Res Commun 327 (2005) 393-398
65. Yoshiji H., Kuriyama S., Yoshii J., et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52 (2003) 1347-1354
66. Chintalgattu V., Nair D.M., and Katwa L.C. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 35 (2003) 277-286
67. Beddy D., Watson R.W., Fitzpatrick J.M., et al. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease. Br J Surg 91 (2004) 72-77
68. Naldini L., Vigna E., Narsimhan R.P., et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6 (1991) 501-504
69. Itakura A., Kurauchi O., Morikawa S., et al. Involvement of hepatocyte growth factor in formation of bronchoalveolar structures in embryonic rat lung in primary culture. Biochem Biophys Res Commun 241 (1997) 98-103
70. Morimoto K., Amano H., Sonoda F., et al. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am J Respir Cell Mol Biol 24 (2001) 608-615
71. Yaekashiwa M., Nakayama S., Ohnuma K., et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin: A morphologic study. Am J Respir Crit Care Med 156 (1997) 1937-1944
72. Harrison P., Bradley L., and Bomford A. Mechanism of regulation of HGF/SF gene expression in fibroblasts by TGFβ1. Biochem Biophys Res Commun 271 (2000) 203-211
73. Marchand-Adam S., Marchal J., Cohen M., et al. Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168 (2003) 1156-1161
74. Yu J., Moon A., and Kim H.R. Both platelet-derived growth factor receptor (PDGFR)-alpha and PDGFR-beta promote murine fibroblast cell migration. Biochem Biophys Res Commun 282 (2001) 697-700
75. Imhof B.A., and Dunon D. Leukocyte migration and adhesion. Adv Immunol 58 (1995) 345-416
76. Kotloff R.M., Little J., and Elias J.A. Human alveolar macrophage and blood monocyte interleukin-6 production. Am J Respir Cell Mol Biol 3 (1990) 497-505
77. Moodley Y.P., Misso N.L., Scaffidi A.K., et al. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol 29 (2003) 490-498
78. Chen Y., Rubin P., Williams J., et al. Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 49 (2001) 641-648
79. Yoshida M., Sakuma J., Hayashi S., et al. A histologically distinctive interstitial pneumonia induced by over expression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Proc Natl Acad Sci USA 92 (1995) 9570-9574
80. O'Brien-Ladner A., Nelson M.E., Kimler B.F., et al. Release of interleukin-1 by human alveolar macrophages after in vitro irradiation. Radiat Res 136 (1993) 37-41
81. Elias J.A., and Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblasts IL-6 production and stabilize IL-6 messenger RNA. J Immunol 145 (1990) 161-166
82. Kyrkanides S., Olschowka J.A., Williams J.P., et al. TNF alpha and IL-1beta mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS radiation injury. J Neuroimmunol 95 (1999) 95-106
83. Johnston C.J., Piedboeuf B., Rubin P., et al. Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res 145 (1996) 762-767
84. Broski A.P., and Halloran P.F. Tissue distribution of IL-10 mRNA in normal mice. Evidence that a component of IL-10 expression is T and B cell-independent and increased by irradiation. Transplantation 57 (1994) 582-592
85. Lindner H., Holler E., Gerbitz A., et al. Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: Interleukin-10 protects against transendothelial migration. Transplantation 64 (1997) 11370-11373
86. Tsujino K., Kodama A., Kanaoka N., et al. Expression of pulmonary mRNA encoding ICAM-1, VCAM-1, and P-selectin following thoracic irradiation in mice. Radiat Med 17 (1999) 283-287
87. Hallahan D.E., and Virudachalam S. Ionizing radiation mediates expression of cell adhesion molecules in distinct histological patterns within the lung. Cancer Res 57 (1997) 2096-2099
88. Kang S.K., Rabbani Z.N., and Folz R.J. Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int J Radiat Oncol Biol Phys 57 (2003) 1056-1066
89. Worthington J., Robson T., Murray M., et al. Modification of vascular tone using iNOS under the control of a radiation-inducible promoter. Gene Ther 7 (2000) 1126-1131
90. Saleh D., Barnes P.J., and Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155 (1997) 1763-1769
91. Inghilleri S., Morbini P., Oggionni T., et al. In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis. Histochem Cell Biol 125 (2006) 661-669
92. Quintero M., Brennan P.A., Thomas G.J., et al. Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: Role of free radical formation. Cancer Res 66 (2006) 770-774
93. Zucker S., Hymowitz M., Conner C., et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. NY Acad Sci 878 (1999) 212-227
94. Susskind H., Hymowitz M.H., Lau Y.H., et al. Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1161-1169
95. Araya J., Maruyama M., Sassa K., et al. Ionizing radiation enhances matrix metalloproteinase-2 production in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 280 (2001) 30-38
96. Hagimoto N., Kuwano K., Nomoto Y., et al. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 16 (1997) 91-101
97. Kazuyoshi K., Hiroyuki M., Naoki H., et al. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol 20 (1999) 53-60
98. Sheard M.A., Uldrijan S., and Vojtesek B. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells. Cancer Res 63 (2003) 7176-7184
99. Martin T.R., Hagimoto N., Nakamura M., et al. Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc 2 (2005) 214-220
100. 1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 59 (2004) 126-129
101. Riha R.L., Yang I.A., Rabnott G.C., et al. Cytokine gene polymorphisms in idiopathic pulmonary fibrosis. Intern Med J 34 (2004) 126-129
102. Quarmby S., Fakhoury H., Levine E., et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79 (2003) 137-143
103. Andreassen C.N., Overgaard J., Alsner J., et al. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 776-783
104. Percy M.J., Mooney S.M., McMullin M.F., et al. A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation. Mol Cancer 2 (2003) 31
105. Koukourakis M.I., Papazoglou D., Giatromanolaki A., et al. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46 (2004) 293-298
106. Epperly M., Bray J., Kraeger S., et al. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther 5 (1998) 196-208
107. Folz R.J., Guan J., Seldin M.F., et al. Mouse extracellular superoxide dismutase: Primary structure, tissue-specific gene expression, chromosomal localization, and lung in situ hybridization. Am J Respir Cell Mol Biol 17 (1997) 393-403
108. Kang S.K., Rabbani Z.N., Folz R.J., et al. Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int J Radiat Biol Oncol Phys 47 (2003) 1056-1066
109. Rabbani Z.N., Anscher M.S., Folz R.J., et al. Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity. BMC Cancer 5 (2005) 59
110. Vujaskovic Z., Batinic-Haberle I., Rabbani Z.N., et al. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med 33 (2002) 857-863
111. Delanian S., Baillet F., Huart J., et al. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase (clinical trial). Radiother Oncol 32 (1994) 12-20
112. Patt H.N., Tyree R., Straube R.L., et al. Cysteine protection against irradiation. Science 110 (1949) 213
113. Koukourakis M.I. Amifostine in clinical oncology: Current use and future applications. Anticancer Drugs 13 (2002) 181-209
114. Komaki R., Lee J.S., Milas L., et al. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: Report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58 (2004) 1369-1377
115. Antonadou D., Petridis A., Synodinou M., et al. Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer. Semin Oncol 30 Suppl (2003) 2-9
116. Movsas B., Scott C., Langer C., et al. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01. J Clin Oncol 23 (2005) 2145-2154
117. Koukourakis M.I., Romanidis K., Froudarakis M., et al. Concurrent administration of docetaxel and stealth liposomal doxorubicin with radiotherapy in non-small cell lung cancer: Excellent tolerance using subcutaneous amifostine for cytoprotection. Br J Cancer 87 (2002) 385-392
118. Gopal R., Tucker S.L., Komaki R., et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56 (2003) 106-113
119. Vujaskovic Z., Feng Q.F., Rabbani Z.N., et al. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity. Exp Lung Res 28 (2002) 577-590
120. Vujaskovic Z., Feng Q.F., Rabbani Z.N., et al. Radioprotection of lungs by amifostine is associated with reduction in profibrogenic cytokine activity. Radiat Res 157 (2002) 656-660
121. Komaki R., Chang J.Y., Wu X., et al. Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Semin Oncol 32 Suppl (2005) S92-S98
122. Terry N.H., Brinkley J., Doig A.J., et al. Cellular kinetics of murine lung: model system to determine basis for radioprotection with keratinocyte growth factor. Int J Radiat Oncol Biol Phys 58 (2004) 435-444
123. Chen L., Brizel D.M., Rabbani Z.N., et al. The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats. Int J Radiat Oncol Biol Phys 60 (2004) 1520-1529
124. Di Sabatino A., Ciccocioppo R., Benazzato L., et al. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment Pharmacol Ther 19 (2004) 1019-1024
125. Bargagli E., Galeazzi M., Bellisai F., et al. Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension. Respiration (2005) December 9, 2005 [Epub].
126. 1 in cultured rat hepatic stellate cells. Pharm Res 23 (2006) 82-89
127. Lin S.L., Chen R.H., Chen Y.M., et al. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. J Am Soc Nephrol 16 (2005) 2702-2713
128. Heeg M.H., Koziolek M.J., Vasko R., et al. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int 68 (2005) 96-109
129. Grygielko E.T., Martin W.M., Tweed C., et al. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. J Pharmacol Exp Ther 313 (2005) 943-951
130. Bonniaud P., Margetts P.J., Kolb M., et al. Progressive transforming growth factor β1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med 171 (2005) 889-898
131. Nakazato H., Oku H., Yamane S., et al. A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level. Eur J Pharmacol 446 (2002) 177-185
132. Card J.W., Racz W.J., Brien J.F., et al. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity. Toxicol Sci 75 (2003) 169-180
133. Ko J., Ross J., Awad H., et al. The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice. J Surg Res 129 (2005) 251-259
134. Hamada N., Kuwano K., and Yamada M. Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice. J Immunol 175 (2005) 1224-1231
135. Yoshio Y., Miyazaki M., Abe K., et al. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Kidney Int 66 (2004) 1677-1685
136. Daniels C.E., Wilkes M.C., Edens M., et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 114 (2004) 1308-1316
137. Nelson D.R., Tu Z., and Soldevila-Pico C. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 38 (2003) 859-868
138. Nakatani-Okuda A., Ueda H., Kashiwamura S., et al. Protection against bleomycin-induced lung injury by IL-18 in mice. Am J Physiol Lung Cell Mol Physiol 289 (2005) L280-L287
139. Escotte S., Tabary O., Dusser D., et al. Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway. Eur Respir J 21 (2003) 574-581
140. Fineschi S., Reith W., Guerne P.A., et al. Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts. FASEB J 20 (2006) 562-564
141. Wen X., Li Y., Hu K., et al. Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. Am J Pathol 167 (2005) 947-957
142. Delanian S., Porcher R., Balla-Mekias S., et al. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21 (2003) 2545-2550
143. Ozturk B., Egehan I., Atavci S., et al. Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: A double-blind randomized trial. Int J Radiat Oncol Biol Phys 58 (2004) 213-219
144. Molteni A., Moulder J.E., Cohen E.F., et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol 76 (2000) 523-532
145. Information about ongoing Radiation Therapy Oncology Group trial. Available at: http://www.rtog.org/meeting/June_06_RTOG_Meeting_Book.pdf. Accessed August 18, 2006.
146. Gore E. Celecoxib and radiation therapy in non-small-cell lung cancer. Oncology 18 Suppl (2004) 10-14
147. Anscher M.S., Chen L., Rabbani Z., et al. Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 255-259